UiPath CEO Daniel Dines sells 45,000 PATH shares at $18.61

UiPath, Inc. (PATH) CEO and Chairman Daniel Dines reported a planned insider stock sale.

Rhea-AI Filing Summary

UiPath, Inc. (PATH) CEO and Chairman Daniel Dines reported a planned insider stock sale. On 12/10/2025, he sold 45,000 shares of Class A common stock at an average price of $18.6107 per share in an open market transaction coded as a sale.

The filing states the sale was made under a qualified Rule 10b5-1 trading plan, which allows preset trades to help separate personal portfolio decisions from non-public company information. Following this transaction, Dines directly beneficially owned 29,108,585 shares of UiPath Class A common stock.

Insider Trade Summary

Net Seller: 45,000 shares

Net Sell 1 txn

Insider Dines Daniel

Role CEO and Chairman

Sold 45,000 shs ($837K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	45,000	$18.6107	$837K

Holdings After Transaction: Class A Common Stock — 29,108,585 shares (Direct)

Footnotes (2)

1. F1. These shares were sold in compliance with a qualified selling plan adopted by the Reporting Person pursuant to Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
2. F2. The range of prices for the transactions reported was from $18.4600 to $18.7400. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did UiPath (PATH) report for 12/10/2025?

On 12/10/2025, UiPath CEO and Chairman Daniel Dines reported selling 45,000 shares of UiPath Class A common stock in an open market transaction.

At what price did Daniel Dines sell UiPath (PATH) shares?

Daniel Dines reported selling 45,000 shares of UiPath Class A common stock at an average price of $18.6107 per share, within a range of $18.4600 to $18.7400.

How many UiPath (PATH) shares does Daniel Dines own after this sale?

After the reported transaction, Daniel Dines beneficially owned 29,108,585 shares of UiPath Class A common stock directly.

Was the UiPath (PATH) insider sale made under a Rule 10b5-1 plan?

Yes. The filing states that the 45,000-share sale by Daniel Dines was made in compliance with a qualified selling plan adopted under Rule 10b5-1.

What is Daniel Dines' role and status at UiPath (PATH)?

Daniel Dines is reported as a Director, 10% Owner, and Officer of UiPath, serving as CEO and Chairman.

Can investors get more detail on the UiPath (PATH) insider trade price levels?

The filing notes the price range was $18.4600 to $18.7400 and that full details on shares sold at each price are available upon request from the company, the SEC staff, or a security holder.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/10/2025 - 04:52 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dines Daniel

(Last) (First) (Middle)

C/O UIPATH, INC., ONE VANDERBILT AVENUE

60TH FLOOR

(Street)

NEW YORK NY 10017

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UiPath, Inc. [ PATH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	CEO and Chairman

3. Date of Earliest Transaction (Month/Day/Year)
12/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	12/10/2025		S		45,000(1)	D	$18.6107(2)	29,108,585	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were sold in compliance with a qualified selling plan adopted by the Reporting Person pursuant to Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.

2. The range of prices for the transactions reported was from $18.4600 to $18.7400. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.

Remarks:

	/s/ Brad Brubaker, Attorney-in-Fact	12/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.